Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial. (Q40261524)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17161727%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

title

Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17161727%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17161727%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

author name string

Sue M Moss

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17161727%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Howard Cuckle

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17161727%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Andy Evans

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17161727%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Louise Johns

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17161727%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Lynda Bobrow

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17161727%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Trial Management Group

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17161727%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

language of work or name

English

0 references

publication date

1 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17161727%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17161727%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

volume

368

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17161727%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

issue

9552

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17161727%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

page(s)

2053-2060

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17161727%20AND%20SRC:MED&resulttype=core&format=json

Long-term effects of mammography screening: updated overview of the Swedish randomised trials

23 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969834-6

7 January 2021

Reduced breast cancer mortality in women under age 50: updated results from the Malmö Mammographic Screening Program

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969834-6

7 January 2021

The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969834-6

7 January 2021

14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969834-6

7 January 2021

The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969834-6

7 January 2021

Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969834-6

7 January 2021

Benefit of mammography screening in women ages 40 to 49 years. Current evidence from randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969834-6

7 January 2021

Efficacy of screening mammography. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969834-6

7 January 2021

European Society of Mastology Consensus Conference on Breast Cancer screening, Paris, 4-5 February 1993: report of the Evaluation Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969834-6

7 January 2021

The randomized trials of breast cancer screening: what have we learned?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969834-6

7 January 2021

Randomised controlled trial of mammographic screening in women from age 40: predicted mortality based on surrogate outcome measures

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969834-6

7 January 2021

Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969834-6

7 January 2021

Pathology characteristics that optimize outcome prediction of a breast screening trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969834-6

7 January 2021

A trial to study the effect on breast cancer mortality of annual mammographic screening in women starting at age 40. Trial Steering Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969834-6

7 January 2021

Randomised controlled trial of mammographic screening in women from age 40: results of screening in the first 10 years

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969834-6

7 January 2021

Adjusting for non-compliance and contamination in randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969834-6

7 January 2021

Number needed to screen: development of a statistic for disease screening.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969834-6

7 January 2021

Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969834-6

7 January 2021

Intermediate determinants of mortality in the evaluation of screening

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969834-6

7 January 2021

Cochrane review on screening for breast cancer with mammography.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969834-6

7 January 2021

All-cause mortality in randomized trials of cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969834-6

7 January 2021

Verification of the cause of death in the trial of early detection of breast cancer. UK Trial of Early Detection of Breast Cancer Group. Trial Co-ordinating Centre

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969834-6

7 January 2021

Determination of cause of death among breast cancer cases in the Swedish randomized mammography screening trials. A comparison between official statistics and validation by an endpoint committee

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969834-6

7 January 2021

Cancers detected and induced, and associated risk and benefit, in a breast screening programme.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969834-6

7 January 2021

Mammographic screening before age 50 years in the UK: comparison of the radiation risks with the mortality benefits

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969834-6

7 January 2021

Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969834-6

7 January 2021

The effect of changing from one to two views at incident (subsequent) screens in the NHS breast screening programme in England: impact on cancer detection and recall rates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969834-6

7 January 2021

The pathological and radiological features of screen-detected breast cancers diagnosed following arbitration of discordant double reading opinions.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969834-6

7 January 2021

10.1016/S0140-6736(06)69834-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17161727%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference